Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(8):636-641; doi:10.1093/jnci/92.8.636
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yang, C.-T.
Right arrow Articles by Jablons, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C.-T.
Right arrow Articles by Jablons, D. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 8, 636-641, April 19, 2000
© 2000 Oxford University Press

Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells

Cheng-Ta Yang, Liang You, Che-Chung Yeh, John Wen-Cheng Chang, Fen Zhang, Frank McCormick, David M. Jablons

Affiliations of authors: C.-T. Yang, Thoracic Oncology Laboratory, University of California, San Francisco Cancer Center, and Division of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan; L. You, F. McCormick, D. M. Jablons (Thoracic Oncology Laboratory), C.-C. Yeh (Molecular Urology Laboratory), J. W.-C. Chang (Department of Surgery), F. Zhang (Department of Ophthalmology), University of California, San Francisco.

Correspondence to: David M. Jablons, M.D., Section of General Thoracic Surgery, University of California, San Francisco, Campus Box 1674, San Francisco, CA 94115 (e-mail: jablonsd{at}surgery.ucsf.edu).

Background: The p14ARF protein encoded by the INK4a/ARF locus promotes degradation of the MDM2 protein and thus prevents the MDM2-mediated inhibition of p53. Homozygous deletion of the INK4a/ARF locus is common in human mesothelioma and may result in the loss of p14ARF and the inactivation of p53. We designed this study to evaluate the biologic and potential therapeutic roles of p14ARF expression in mesothelioma cells. Methods and Results: We constructed Adp14, an adenoviral vector carrying human p14ARF complementary DNA, and used it to transfect human mesothelioma cell lines H28, H513, H2052, and MSTO-211H. Overexpression of p14ARF led to increased amounts of p53 and the p21WAF proteins and dephosphorylation of the retinoblastoma protein. The growth rate of mesothelioma cells was inhibited markedly by infection with Adp14 compared with mock infection or infection with a control adenovirus vector, AdCtrl. Overexpression of p14ARF induced G1-phase cell cycle arrest and apoptotic cell death. Cytotoxicity assays showed that Adp14 had a statistically significantly (P = .002) greater effect on colon cancer (HCT116) cell lines containing two copies of the wild-type p53 gene than on p53-null cells, suggesting that functional p53 is a critical determinant of p14ARF-mediated cytotoxicity. Conclusions: The transfection of p14ARF into mesothelioma cells led to the overexpression of p14ARF, which resulted in G1-phase arrest and apoptotic cell death. These results suggest that this gene therapy-based approach may be of use in the treatment of mesothelioma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am Soc Clin Oncol Ed BookHome page
H. L. Kindler, R. Bueno, and J. R. Testa
New Biomarkers, Surgical Controversies, and Rationally Targeted Therapies for Malignant Mesothelioma
ASCO Educational Book, January 1, 2008; 2008(1): 354 - 361.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. S. Abayasiriwardana, D. Barbone, K.-U. Kim, C. Vivo, K. K. Lee, T. B. Dansen, A. E. Hunt, G. I. Evan, and V. C. Broaddus
Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim
Mol. Cancer Ther., October 1, 2007; 6(10): 2766 - 2776.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J.-S. Kim, C. Lee, C. L. Bonifant, H. Ressom, and T. Waldman
Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA
Mol. Cell. Biol., January 15, 2007; 27(2): 662 - 677.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. W. Robinson and R. A. Lake
Advances in malignant mesothelioma.
N. Engl. J. Med., October 13, 2005; 353(15): 1591 - 1603.
[Full Text] [PDF]

Home page
 J. Virol.Home page
B. Hann and A. Balmain
Replication of an E1B 55-Kilodalton Protein-Deficient Adenovirus (ONYX-015) Is Restored by Gain-of-Function Rather than Loss-of-Function p53 Mutants
J. Virol., November 1, 2003; 77(21): 11588 - 11595.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. B. Illei, V. W. Rusch, M. F. Zakowski, and M. Ladanyi
Homozygous Deletion of CDKN2A and Codeletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas
Clin. Cancer Res., June 1, 2003; 9(6): 2108 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Russo, D. Arzani, S. Trombino, and C. Falugi
c-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 37 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Gattacceca, Y. Pilatte, C. Billard, I. Monnet, S. Moritz, J. Le Carrou, M. Eloit, and M.-C. Jaurand
Ad-IFN{gamma} Induces Antiproliferative and Antitumoral Responses in Malignant Mesothelioma
Clin. Cancer Res., October 1, 2002; 8(10): 3298 - 3304.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Xia, Z. Xu, X. Yuan, K. Uematsu, L. You, K. Li, L. Li, F. McCormick, and D. M. Jablons
Induction of Apoptosis in Mesothelioma Cells by Antisurvivin Oligonucleotides
Mol. Cancer Ther., July 1, 2002; 1(9): 687 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Hewitt, C. Lee Wu, G. Evans, A. Howell, R. G. Elles, R. Jordan, P. Sloan, A. P. Read, and N. Thakker
Germline mutation of ARF in a melanoma kindred
Hum. Mol. Genet., May 16, 2002; 11(11): 1273 - 1279.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A Baldi, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, et al.
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
Thorax, April 1, 2002; 57(4): 353 - 356.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Russo, C. Ottoboni, D. Malacarne, A. Crippa, J.-F. Riou, and P. M. O'Connor
Nonpeptidomimetic Farnesyltransferase Inhibitor RPR-115135 Increases Cytotoxicity of 5-Fluorouracil: Role of p53
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 220 - 226.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Chattopadhyay, M. K. Ghosh, A. Mal, and M. L. Harter
Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells
J. Virol., October 15, 2001; 75(20): 9844 - 9856.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
C. Ottoboni, A. Crippa, C. Falugi, and P. Russo
Induction of micronuclei by a new non-peptidic mimetic farnesyltransferase inhibitor RPR-115135: role of gene mutations
Mutagenesis, September 1, 2001; 16(5): 423 - 430.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-T. Yang, L. You, K. Uematsu, C.-C. Yeh, F. McCormick, and D. M. Jablons
p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53
Cancer Res., August 1, 2001; 61(16): 5959 - 5963.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
W. Liu, E. Bodle, J. Y. Chen, M. Gao, G. D. Rosen, and V. C. Broaddus
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapy Cooperate to Induce Apoptosis in Mesothelioma Cell Lines
Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 111 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Pilatte, C. Vivo, A. Renier, L. Kheuang, A. Greffard, and M.-C. Jaurand
Absence of SV40 Large T-Antigen Expression in Human Mesothelioma Cell Lines
Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 788 - 793.
[Abstract] [Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.